Pierrel S.p.A.: THE BOARD APPROVES THE INTERIM FINANCIAL REPORT OF THE PIERREL GROUP AT 30 JUNE 2020
(WorldNews Italy)

PRESS RELEASE PIERREL S.P.A. THE BOARD APPROVES THE INTERIM FINANCIAL REPORT OF THE PIERREL GROUP AT 30 JUNE 2020 THE MAIN ECONOMIC-FINANCIAL OBJECTIVES OF THE PIERREL GROUP FOR THE YEAR 2020 WERE UPDATED due to the COVID-19 pandemic Consolidated results at 30 June 2020, driven by sales of the Orabloc® drug, under the Pierrel brand: Revenues of € 10.2 million (showing an increase of some 9% compared to 30 June 2019, when they were some € 9.4 million). EBITDA positive for about € 2.2 million, showing a marked improvement compared to 30 June 2019, when it was positive for about € 0.9 million. EBIT positive for about € 1.6 million, showing a marked improvement compared to 30 June 2019, when it...